reaction of activated aziridine ring opening led to the discovery of a novel class of antitumor compounds. The analogues 10i-k, 11l-n, 12o-p, and 16q-s were obtained from treating cantharidinimide 6 and analogues (7, 8, and 13) with activated aziridines, which produced a series of ring-opened products including normal and abnormal types. Some of these compounds showed cytotoxic effects in vitro against
合成了邻苯二甲
酰亚胺衍
生物5a-h,包括含有
嘧啶基,
吡嗪基,氢,
噻唑基和
恶唑基的
磺胺酰胺。通过活化的
氮丙啶开环反应来修饰邻苯二甲
酰亚胺,导致发现了新型的抗肿瘤化合物。类似物10i-k,11l-n,12o-p和16q-s是通过用活化的
氮丙啶处理邻苯二甲
酰亚胺6和类似物(7、8和13)而制得的,这些化合物产生了一系列的开环产物,包括正常的和异常类型。这些化合物中的一些在体外对HL-60,Hep3B,MCF7和
MDA-MB-231癌细胞显示出细胞毒作用。最有效的细胞抑制化合物N-cantharidinimido-
磺胺二甲
嘧啶(5a)具有抗HL-60和抗Hep3B细胞的活性。